But in progressive forms of MS, remissions usually become shorter as the disease advances.
However, the frequency of CCSVI positivity was also increased in progressive forms of MS compared to the non-progressive forms of MS. We reasoned that because HLA DRB1*1501 was well established as a genetic factor associated with the risk of developing MS, it would provide a reference relative to which the role of CCSVI could be evaluated.
Evidence for mitigation of disease worsening in progressive forms of MS remains sparse, particularly in patients with PPMS.
During an inflammatory attack, e.g., an exacerbation in RRMS, or during ongoing pathology in progressive forms of MS, these cells can undergo degeneration resulting in the release of heme-containing proteins, which can contribute to pathological iron deposits.
These results have implications in understanding the clinical effects observed with laquinimod in two Phase III trials, and they provide the rationale of using laquinimod in progressive forms of MS. None declared.
They also observed that subclinical ON could also damage axons in progressive forms of MS. These findings could be explained either by a subclinical ongoing inflammation or by neuronal cell death.
Indeed, they are able to delay MS relapse and slow disease progression for RRMS (relapsing-remitting multiple sclerosis), but fail to show significant benefit in progressive forms of MS such as SPMS (secondary progressive form of MS) and PPMS (primary progressive form of MS) (Goodin et al., 2002; Sorensen et al., 2005; Miller and Leary, 2007).
In progressive forms of cutaneous leishmaniasis, parasites and parasite molecules are continuously observed in the interior of the mononuclear phagocytes in the skin lesion and in the marginal sinus of the draining lymph nodes, suggesting that these phagocytes continuously transport parasite and parasite molecules [ 4].
GADA levels were significantly higher (P < 0.05) in IA-2A positive than in IA-2A negative patients in slowly progressive form, but IA-2A levels did not differ significantly between GADA positive and GADA negative patients.
Moreover, as an NF-κB family member associated with the control of the adaptive immune response and the response to metabolic stress, RelB may be of particular interest in the emergence of progressive form of CLL since the alternative NF-κB pathway is potentially involved in both early and late differentiation of B cells [ 36, 37].
Relapsing remitting disease is characterized by some level of myelin repair, whereas in the progressive form myelin repair seems to be insufficient or ineffectual resulting in progressive disability without any observable signs of recovery.
